The All Panel Cytogenetics FISH BCR/ABL TEL/AML1 MLL E2A test is an advanced diagnostic tool used to detect specific genetic abnormalities associated with various hematological malignancies, including leukemia and lymphoma. This test employs Fluorescence In Situ Hybridization (FISH) technology, which allows for the visualization of genetic changes at the cellular level, providing critical information for accurate diagnosis and treatment planning.
Turnaround time for results is approximately 10 days. The test requires a sample of bone marrow or peripheral blood, which should be transported immediately. A Doctor’s prescription is necessary for this test, except in cases of surgery, pregnancy, or travel plans abroad.